Biotechnology

Progress in Lyme Disease Vaccine Development

by
Vaccine_development

Valneva reports the subjects in Phase II clinical trial of Lyme disease vaccine develop antibodies.  The results were positive enough to inspire Pfizer to join with Valneva to continue testing in the next phase of clinical trials and, hopefully, bring this to market. Find out more about the vaccine strategy and Lyme disease: Read More … Read more

Detecting COVID-19 in Breath

by
covid-19 breathalyzer

Researchers in academia and biotech firms are working to develop devices that can detect if a person has COVID-19 by analyzing their breath. Respiratory infections, like the one caused by the SARS-COV-2 virus and influenza viruses, cause changes in our metabolism. These changes result in volatile organic chemicals, which are present in exhaled breath. Several … Read more